Home

Nuwellis, Inc. - Common Stock (NUWE)

1.2400
0.00 (0.00%)

Nuwellis Inc is a medical technology company focused on developing innovative solutions for treating fluid overload in patients, specifically targeting those with heart failure and other conditions that lead to the accumulation of excess fluid

The company’s flagship product is designed to enhance the process of fluid removal through a unique approach that combines advanced technology with user-friendly operation, aiming to improve patient outcomes and quality of life. By harnessing cutting-edge medical advancements, Nuwellis strives to offer safer and more effective treatment options for patients who struggle with the complications associated with fluid retention.

SummaryNewsPress ReleasesChartHistoricalFAQ
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030
EQNX::TICKER_START (NASDAQSILO),NASDAQ:BXRXNASDAQBXRX)(NASDAQ:HOTHNASDAQHOTH,(NASDAQ:KALANASDAQ),(NASDAQ:NUWENUWE) EQNX::TICKER_END
Via FinancialNewsMedia · December 30, 2022
Nuwellis (NASDAQ: NUWE) Reports Clinical Data Showing 100% Survival Rate Using Ultrafiltration in High-Risk CABG Patients
Nuwellis, Inc. (NASDAQNUWE) is engaged as a medical device company, which is focused on the development and commercialization of
Via Spotlight Growth · August 31, 2022